Aeglea BioTherapeutics
increased mortality and high risk of severe complications | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
29 of 39
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
May 2023
increased mortality and high risk of severe complications | Aeglea BioTherapeutics
Investor Presentation
April 2023
increased mortality and high risk of severe complications | Aeglea BioTherapeutics
Related slides by other companies
AngloAmerican
Results
February 2024
our ratings reflect our leading capabilities in sustainable mining | AngloAmerican
Continental Airlines
Investor Conference
March 2001
continental high return low risk opportunities | Continental Airlines
Central Pacific Financial
Results
April 2021
high risk industries criticized as of total criticized criticized total loans of total loan portfolio | Central Pacific Financial
Deliveroo
Results
August 2023
selection differentiated high quality options | Deliveroo
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io